Overall Trading Platform
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Adaptive Biotechnologies Corporation is a biotechnology business based in the US. Adaptive Biotechnologies Corporation shares (ADPT) are listed on the NYSE and all prices are listed in US Dollars. Adaptive Biotechnologies Corporation employs 622 staff and has a trailing 12-month revenue of around USD$115.9 million.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Since the stock market crash in March caused by coronavirus, Adaptive Biotechnologies Corporation's share price has had significant positive movement.
Its last market close was USD$43.34, which is 21.18% up on its pre-crash value of USD$34.16 and 185.32% up on the lowest point reached during the March crash when the shares fell as low as USD$15.19.
If you had bought USD$1,000 worth of Adaptive Biotechnologies Corporation shares at the start of February 2020, those shares would have been worth USD$755.26 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,444.52.
|Latest market close||USD$43.34|
|52-week range||USD$30.41 - USD$71.25|
|50-day moving average||USD$39.7457|
|200-day moving average||USD$50.36|
|Wall St. target price||USD$61.2|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-4.344|
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-05-07)||N/A|
|1 month (2021-04-15)||0.72%|
|3 months (2021-02-18)||-29.30%|
|6 months (2020-11-18)||-10.58%|
|1 year (2020-05-18)||10.28%|
|2 years (2019-05-14)||N/A|
|3 years (2018-05-14)||N/A|
|5 years (2016-05-14)||N/A|
|Revenue TTM||USD$115.9 million|
|Gross profit TTM||USD$-40,220,000|
|Return on assets TTM||-10.24%|
|Return on equity TTM||-24.34%|
|Market capitalisation||USD$4.8 billion|
TTM: trailing 12 months
There are currently 4.8 million Adaptive Biotechnologies Corporation shares held short by investors – that's known as Adaptive Biotechnologies Corporation's "short interest". This figure is 9.2% up from 4.4 million last month.
There are a few different ways that this level of interest in shorting Adaptive Biotechnologies Corporation shares can be evaluated.
Adaptive Biotechnologies Corporation's "short interest ratio" (SIR) is the quantity of Adaptive Biotechnologies Corporation shares currently shorted divided by the average quantity of Adaptive Biotechnologies Corporation shares traded daily (recently around 806631.58783784). Adaptive Biotechnologies Corporation's SIR currently stands at 5.92. In other words for every 100,000 Adaptive Biotechnologies Corporation shares traded daily on the market, roughly 5920 shares are currently held short.
However Adaptive Biotechnologies Corporation's short interest can also be evaluated against the total number of Adaptive Biotechnologies Corporation shares, or, against the total number of tradable Adaptive Biotechnologies Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Adaptive Biotechnologies Corporation's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Adaptive Biotechnologies Corporation shares in existence, roughly 30 shares are currently held short) or 0.044% of the tradable shares (for every 100,000 tradable Adaptive Biotechnologies Corporation shares, roughly 44 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Adaptive Biotechnologies Corporation.
This is what you should know about travelling to the Netherlands from Singapore.
Here’s what you need to know about travelling to South Africa from Singapore.
Here’s what you need to know when travelling to Mexico from Singapore.
Here’s everything we know so far about The Honest Company IPO and how to buy in from Singapore.
Here’s what you need to know about travelling to India from Singapore.
Find out what you need to know about heading to Greece from Singapore.
Who can travel, the quarantine and immunisation rules and everything else you need to travel to New Zealand from Singapore.
Who can travel, the quarantine and immunisation rules and everything else you need to travel to Indonesia from Singapore.
From who can travel to quarantine rules – we answer your questions about flying from Singapore to Canada.
Here’s what you should know about travelling to Spain from Singapore.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.